Your browser doesn't support javascript.
loading
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus.
Wincup, Chris; Dunn, Nicky; Ruetsch-Chelli, Caroline; Manouchehrinia, Ali; Kharlamova, Nastya; Naja, Meena; Seitz-Polski, Barbara; Isenberg, David A; Fogdell-Hahn, Anna; Ciurtin, Coziana; Jury, Elizabeth C.
Afiliação
  • Wincup C; Centre for Rheumatology Research, Division of Medicine, University College London, London, UK.
  • Dunn N; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Ruetsch-Chelli C; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Manouchehrinia A; Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, Nice, France.
  • Kharlamova N; Centre Méditerranéen de Médecine Moléculaire (C3M), INSERM U1065, Université Côte d'Azur, Nice, France.
  • Naja M; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, Nice, France.
  • Seitz-Polski B; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Isenberg DA; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Fogdell-Hahn A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Ciurtin C; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Jury EC; Centre for Adolescent Rheumatology Research, Division of Medicine, University College London, London, UK.
Rheumatology (Oxford) ; 62(7): 2601-2610, 2023 07 05.
Article em En | MEDLINE | ID: mdl-36370065

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico / Anticorpos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico / Anticorpos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido